v3.25.2
Share Capital
6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
Share Capital

9. SHARE CAPITAL

 

 

 

Common shares, which include the Company’s Subordinate Voting Shares, Multiple Voting Shares and Super Voting Shares, are classified as equity. Incremental costs directly attributable to the issuance of common shares are recognized as a deduction from equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the applicable vesting periods are recorded as share capital. Income tax relating to transaction costs of an equity transaction is accounted for in accordance with ASC 740, Income Taxes.

 

(a) Authorized

The Company has the following classes of share capital, with each class having no par value:

 

(i) Subordinate Voting Shares

The holders of the Subordinate Voting Shares are entitled to receive dividends which may be declared from time to time and are entitled to one vote per share at meetings of the Company’s shareholders. All Subordinate Voting Shares are ranked equally with regard to the Company’s residual assets. The Company is authorized to issue an unlimited number of no par value Subordinate Voting Shares.

(ii) Multiple Voting Shares

Each Multiple Voting Share is entitled to 100 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Multiple Voting Shares.

(iii) Super Voting Shares

Each Super Voting Share is entitled to 1,000 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares or one Multiple Voting Share. The Company is authorized to issue an unlimited number of Super Voting Shares.

 

(b) Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

 

 

 

Issued and Outstanding

 

 

Subordinate
Voting
Shares

 

Multiple
Voting
Shares

 

Super
Voting
Shares

As at January 1, 2025

 

211,128,045

 

37,623

 

206,690

Issuance of shares associated with investment interests

 

77,525

 

 

Distribution of deferred shares

 

244,986

 

 

Issuance of shares upon exercise of options

 

204,988

 

 

Issuances of shares upon vesting of RSUs

 

1,179,778

 

 

Issuance of shares to non-employee contractors

 

27,873

 

 

Repurchase of Subordinate Voting Shares

 

(5,718,000)

 

 

As at June 30, 2025

 

207,145,195

 

37,623

 

206,690

 

 

9. SHARE CAPITAL (Continued)

 

 

 

(i) Distribution of Deferred Shares

 

As part of the consideration exchanged for acquisitions completed in previous periods, the Company deferred the distribution of Subordinate Voting Shares to secure the Company's indemnification rights associated with post-acquisition costs.

 

The following table summarizes the activity during the six months ended June 30, 2025:

 

 

Related Acquisition

 

Mobley Pain Management and Wellness Center, LLC and Canwell Processing, LLC

LeafLine Industries, LLC

Total

 

 

 

 

As at January 1, 2025

168,333

76,665

244,998

Distributed Shares

(168,333)

(76,653)

(244,986)

Cancelled Shares

(12)

(12)

As at June 30, 2025

 

(ii) Repurchase of Subordinate Voting Shares

 

On September 13, 2024, the Company's Board of Directors authorized the repurchase of up to 10,573,860 of its Subordinate Voting Shares over a 12-month period at an aggregate cost of up to $50,000 thousand. During the six months ended June 30, 2025, the Company repurchased 5,718,000 Subordinate Voting Shares at an average price of $4.34 per share. As of June 30, 2025, the total remaining repurchase ability of the Company was approximately $15,600 thousand.

 

(c) Stock-Based Compensation

The Company operates equity settled stock-based remuneration plans for its eligible directors, officers, employees and consultants. All goods and services received in exchange for the grant of any stock-based payments are measured at their fair value unless the fair value cannot be estimated reliably. If the Company cannot estimate reliably the fair value of the goods and services received, the Company measures their value indirectly by reference to the fair value of the equity instruments granted. For transactions with employees and others providing similar services, the Company measures the fair value of the services by reference to the fair value of the equity instruments granted. Equity settled stock-based payments under stock-based payment plans are ultimately recognized as an expense in profit or loss with a corresponding credit to equity.

In June 2018, the Company established the Green Thumb Industries Inc. 2018 Stock and Incentive Plan, which was amended by Amendment No. 1, Amendment No. 2, Amendment No. 3 and Amendment No. 4 thereto (as amended, the “Plan”). The maximum number of RSUs and options outstanding under the Plan at any time shall not exceed 15% of the then issued and outstanding shares on an as-converted basis.

The Company recognizes compensation expense for RSUs and options on a straight-line basis over the requisite service period of the award. Non-market vesting conditions are included in the assumptions about the number of options that are expected to become exercisable. Estimates are subsequently revised if there is any indication that the number of options expected to vest differs from the previous estimate. Any cumulative adjustment prior to vesting is recognized in the current period with no adjustment to prior periods for expense previously recognized. Option and RSU awards generally vest over three years, and options typically have a life of seven to ten years. Option grants under the Plan are determined by the Compensation Committee of the Company’s Board of Directors with the option price set at no less than 100% of the fair market value of a share on the date of grant.

 

 

 

9. SHARE CAPITAL (Continued)

 

 

 

(c) Stock-Based Compensation (Continued)

Stock option activity is summarized as follows:

 

Number of Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life

Balance as of December 31, 2024

8,238,472

$10.10

4.07

Granted

954,402

5.94

 

Exercised

(204,988)

6.52

 

Forfeited

(869,817)

9.10

 

Balance as of June 30, 2025

8,118,069

$11.31

4.37

Exercisable as of June 30, 2025

5,725,505

$0.00

 

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the six months ended June 30, 2025 and the year ended December 31, 2024, using the following ranges of assumptions:

 

June 30,

December 31,

 

2025

2024

Risk-free interest rate

3.75% - 4.33%

2.72% - 3.92%

Expected dividend yield

0%

0%

Expected volatility

62% - 64%

62% - 64%

Expected option life

3.76 - 4.68 years

4.46 - 4.5 years

 

As permitted under ASC 718, the Company has made an accounting policy choice to prospectively account for forfeitures when they occur.

 

The following table summarizes the number of unvested RSU awards as of June 30, 2025 and December 31, 2024 and the changes during the six months ended June 30, 2025:

 

 

Number of Shares

 

Weighted Average Grant Date Fair Value

Unvested Shares at December 31, 2024

 

7,678,310

$

11.14

Granted

 

5,482,366

 

5.79

Forfeited

 

(901,850)

 

9.21

Vested

 

(1,179,778)

 

11.59

Unvested Shares at June 30, 2025

 

11,079,048

$

8.49

 

The stock-based compensation expense for the three and six months ended June 30, 2025 and 2024 was as follows:

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

2025

 

2024

 

 

(in thousands)

 

(in thousands)

Stock options expense

$

1,766

$

2,637

$

3,859

$

5,694

Restricted Stock Units

 

10,200

 

6,229

 

18,416

 

9,662

Total Stock Based Compensation Expense

$

11,966

$

8,866

$

22,275

$

15,356

 

As of June 30, 2025, $85,707 thousand of total unrecognized expense related to stock-based compensation awards is expected to be recognized over a weighted-average period of 2.14 years.